chronic hepatitis C infection

December 22, 2014December 22, 2014

Viekira Pak™ From AbbVie Approved By FDA For Chronic Genotype 1 (GT1) Hepatitis C

Hepatitis C, News

Viekira Pak™ from AbbVie recently received FDA approval for the treatment of people suffering with chronic genotype 1 (GT1) hepatitis C. The recently approved Viekira, with or without ribavirin (RBV), is an oral interferon-free treatment for patients ... Read more

November 21, 2014November 21, 2014

First Oral Combination Drug for Hep C Approved in Europe

Hepatitis C, News

Gilead Sciences, Inc. recently announced that the European Commission has finally granted marketing authorization for their novel hepatitis C treatment Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg), which is the first and only once-a-day ... Read more

November 3, 2014November 3, 2014

Swedish County Councils Signs Agreement for Hepatitis C Therapy Olysio

Hepatitis C, News

The Swedish county councils has established a risk-sharing agreement with research-based pharmaceutical company Medivir AB for the medication Olysio (simeprevir) for hepatitis C, including its treatment costs, as a way of making ... Read more